CD8A and neoplasm: Moreover, IL15Rα + TAMs, which express high levels of IL-15Rα, not only reduce CX3C chemokine ligand 1 levels in tumor cells but also inhibit CD8 + T-cell recruitment through the IL-15/IL-15Rα complex, contributing to poorer survival outcomes in breast cancer patients [79].